Alumni

Ventilation System Work at Macdonald Campus Library Begins May 12

admin — Fri, 09 May 2025 13:31:39 +0000

Beginning May 12, construction will take place at the Macdonald Campus Library to address persistent condensation and leaking caused by inadequate insulation in parts of the building’s ventilation system. To carry out this work safely, special precautions are necessary due to the presence of asbestos in the Barton Building. A Sealed Access System (SAS), which allows construction work to be enclosed and contained, will be positioned throughout various library spaces over the course of the project.

CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research

admin — Thu, 28 Nov 2024 14:06:34 +0000

Montréal, November 28th – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at �󷢲�Ʊƽ̨, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to provide patients with safer and more effective therapeutic options, particularly for treating cancer, rare diseases, and preventing various infectious diseases.

Remembering Emil Skamene (1941–2024), pioneer in genetic research at �󷢲�Ʊƽ̨

admin — Mon, 06 Jan 2025 17:13:51 +0000

It is with deep sadness that we remember Emil Skamene, a pioneer in genetic research at �󷢲�Ʊƽ̨.

His groundbreaking work on host genetic susceptibility to infections has shaped the field for over three decades.

Skamene’s legacy continues to inspire scientists, including D2R’s Chief Scientific Officer, Philippe Gros, who, alongside Professor Erwin Schurr, honors him in a heartfelt eulogy published in Nature Genetics.

https://www.nature.com/articles/s41588-024-02028-7

Prescribing anti-swelling drug reduces immune response weeks after last dose

admin — Wed, 26 Feb 2025 16:05:58 +0000

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

Event | Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder | November 14, 2024

admin — Tue, 12 Nov 2024 14:30:50 +0000

Dear Colleagues,

Please see the next Medical Genetics Grand Rounds scheduled talk below:

Project to create AI model for ALS receives Génome Québec funding

admin — Mon, 17 Mar 2025 15:29:17 +0000

$400,000 will fuel public-private collaboration to discover new disease biomarkers

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Event | Workshop in Precision Health and Medicine | January 9, 2025

admin — Mon, 25 Nov 2024 18:16:42 +0000

First Hybrid Workshop on Precision Health and Medicine

Synergizing our strengths in new technologies in omics, digital sciences, and translational medicine to advance patient care.

This event is organized in partnership between University of Bern and �󷢲�Ʊƽ̨. This partnership between the universities aims to synergistically harness the power of new technologies in omics, digital sciences, and translational medicine to advance patient care.

Event details:

An open solution to improving research reproducibility

admin — Wed, 18 Dec 2024 16:12:19 +0000

Academic and industry scientists collaborate on a new method to characterize research antibodies

New publication in Science from the Bernard lab with former and current Cell Biology graduate students Emilie Brûlé and Hailey Schultz

admin — Thu, 20 Mar 2025 17:56:32 +0000

Myostatin is a paracrine myokine that regulates muscle mass in a variety of species, including humans. In this work, they report a functional role for myostatin as an endocrine hormone that directly promotes pituitary follicle-stimulating hormone (FSH) synthesis and thereby ovarian function in mice. Previously, this FSH-stimulating role was attributed to other members of the transforming growth factor-β family, the activins. Their results both challenge activin's eponymous role in FSH synthesis and establish an unexpected endocrine axis between skeletal muscle and the pituitary gland.

Six principal investigators from The Neuro receive CIHR grants

admin — Mon, 10 Feb 2025 18:44:57 +0000

Projects include important research on Parkinson’s, glioblastoma and dementia

Open Science project funded for $1.5M

admin — Tue, 12 Nov 2024 16:51:24 +0000

YCharOS antibody characterization platform addresses the “reproducibility crisis” in research

An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.

YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.

D2R announces new round of funding, investing $1.5 million to advance research in RNA therapeutics and to support �󷢲�Ʊƽ̨ Centres and Institutes

admin — Thu, 19 Dec 2024 14:21:58 +0000

Montreal – December 19, 2024 – The D2R (DNA to RNA) Initiative is proud to announce the recipients of its latest round of funding, awarding a total of $1.5 million to four principal investigators and five �󷢲�Ʊƽ̨ Centres and Institutes. These awards are designed at advancing research in RNA therapeutics by facilitating industry collaboration and supporting the next generation of scientific leaders as well as research Centres and Institutes.

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

admin — Tue, 25 Mar 2025 18:37:02 +0000

Free, online training program strengthens training and brings specialized care to communities across Quebec

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub. Under the direction of Julie Scorah, PhD, this milestone ensures that specialized knowledge reaches underserved communities.

AI analysis of healthcare records reveals key factors in autism diagnosis

admin — Wed, 26 Mar 2025 15:23:21 +0000

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Fifteen new or renewed Canada Research Chairs awarded to �󷢲�Ʊƽ̨

admin — Thu, 14 Nov 2024 17:05:33 +0000

$13.8 million in federal funding for �󷢲�Ʊƽ̨’s cohort of 10 new, five renewed Canada Research Chairs